IP Verse

Universit Paris Saclay competitive analysis

Latest patents of Universit Paris Saclay opposed by its competitors

Explore Universit Paris Saclay's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 15, 2026
Patent NumberPublication DateTitleTotal Oppositions
EP4359795
Jan 14, 2026Methods For Diagnosing A Cancer- Or Antibiotics-Induced Dysbiosis And Their Use For Improving Cancer Treatment By Immunotherapy1
EP3684786
Aug 14, 2024Mutated Glycoprotein Of Vesicular Stomatitis Virus3
EP3152234
Jun 26, 2024Antibody Which Is Directed Against Galectin-9 And Is An Inhibitor Of The Suppressor Activity Of Regulatory T Lymphocytes1
EP3066203
Nov 8, 2023New Alzheimer'S Disease Animal Model1
EP3320101
Aug 11, 2021Methods And Pharmaceutical Compositions For Expressing A Polynucleotide Of Interest In The Peripheral Nervous System Of A Subject1

Latest PTAB cases involving Universit Paris Saclay

Discover the latest PTAB cases involving Universit Paris Saclay, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Universit Paris Saclay with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 15, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
UNIVERSIT PARIS SACLAY - 6 - -
BOULT WADE TENNANT62 - - -
CHRISTOPH THEN/RUTH TIPPE/ SYLVIA HAMBERGER1 - - -
DORRIES11 - - -